HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

I Yanagisawa Selected Research

YM358

5/2001Comparison of the angiotensin II type 1-receptor antagonist YM358 and the angiotensin-converting enzyme inhibitor enalapril in rats with cardiac volume overload.
2/2000Effects of YM358, an angiotensin II type 1 (AT1) receptor antagonist, and enalapril on blood pressure and vasoconstriction in two renal hypertension models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


I Yanagisawa Research Topics

Disease

1Cardiomegaly (Heart Hypertrophy)
05/2001
1Body Weight (Weight, Body)
05/2001
1Heart Failure
05/2001
1Renal Hypertension
02/2000
1Hypertension (High Blood Pressure)
02/2000

Drug/Important Bio-Agent (IBA)

2YM358IBA
05/2001 - 02/2000
2Angiotensin IIIBA
05/2001 - 02/2000
2EnalaprilFDA LinkGeneric
05/2001 - 02/2000
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
05/2001

Therapy/Procedure

1Oral Administration
05/2001